LUT014

CAS No. 2274819-46-2

LUT014( —— )

Catalog No. M24036 CAS No. 2274819-46-2

LUT014 is a B-Raf inhibitor (IC50: 11.7 nM) and developed to decrease dose-limiting acneiform lesions associated with EGFR Inhibitors treatment.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 96 In Stock
5MG 83 In Stock
10MG 113 In Stock
25MG 208 In Stock
50MG 286 In Stock
100MG 401 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LUT014
  • Note
    Research use only, not for human use.
  • Brief Description
    LUT014 is a B-Raf inhibitor (IC50: 11.7 nM) and developed to decrease dose-limiting acneiform lesions associated with EGFR Inhibitors treatment.
  • Description
    LUT014 is a B-Raf inhibitor (IC50: 11.7 nM) and developed to decrease dose-limiting acneiform lesions associated with EGFR Inhibitors treatment.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    B-Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2274819-46-2
  • Formula Weight
    528.49
  • Molecular Formula
    C27H19F3N8O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (94.61 mM; Need ultrasonic);H2O:< 0.1 mg/mL (insoluble)
  • SMILES
    Cc1ccc2c(Nc3cccc(OC(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ncnc2c1[nH]cn2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Noa Shelach. Novel braf inhibitors and use there of for treatment of cutaneous reactions. WO2019026065A2.
molnova catalog
related products
  • TBAP-001

    TBAP-001 is a RAF kinase inhibitor, with an IC50 of 62 nM in BRAF V600E kinase assay and an IC50 of 18 nM in Cell-Based Phosho-ERK Assay.

  • R18

    Antagonist of 14.3.3 proteins (KD ≈80 nM). Competitively inhibits 14.3.3-ligand interactions without requiring phosphorylation. Blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S.

  • Vemurafenib

    Vemurafenib (PLX-4032;RG7204;RO5185426) is a potent, selective B-RAF V600E inhibitor with IC50 of 30 nM.